UTAMAMALAYSIADUNIAPOLITIKVIDEOHIBURANSUKANGAYA HIDUPBISNESENGLISHPODCASTFOTORANCANGANTEKNOLOGI

molnupiravir

Dapatkan berita terkini mengenai molnupiravir dari Astro Awani

Thailand cadang beli ubat antiviral, kit ujian bernilai 4 billion baht

Thailand cadang beli ubat antiviral, kit ujian bernilai 4 billion baht

Ubat antiviral bernilai 3.995 bilion baht merangkumi 165 juta tablet Favipiravir dan Molnupiravir dan 57,000 vial Remdesivir serta 1 juta kit ujian pantas.
Mon Jul 18 2022
COVID-19: PKBD beri kelulusan bersyarat penggunaan pil antiviral Molnupiravir

COVID-19: PKBD beri kelulusan bersyarat penggunaan pil antiviral Molnupiravir

Kapsul Lagevrio tersebut diluluskan untuk merawat COVID-19 kategori ringan hingga sederhana pada orang dewasa.
Fri Apr 08 2022
Malaysia to receive Pfizer's Paxlovid for COVID-19 treatment in two weeks - Khairy

Malaysia to receive Pfizer's Paxlovid for COVID-19 treatment in two weeks - Khairy

Malaysia had purchased 110,000 patient-courses (for 110,000 patients) to be given to high-risk individuals.
Sat Mar 05 2022
Tiga pengeluar ubat Korea Selatan bakal hasilkan pil COVID-19 Merck

Tiga pengeluar ubat Korea Selatan bakal hasilkan pil COVID-19 Merck

Ia bagi menghasilkan pil antiviral Molnupiravir untuk dibekalkan ke 105 negara.
Fri Jan 21 2022
Dozens of firms to make cheap version of Merck COVID pill for poorer nations

Dozens of firms to make cheap version of Merck COVID pill for poorer nations

Nearly 30 generic drugmakers in Asia, Africa and the Middle East will make cheap versions of Merck & Co's COVID-19 pill.
Fri Jan 21 2022
Indonesia hasilkan pil antiviral COVID-19 tidak lama lagi

Indonesia hasilkan pil antiviral COVID-19 tidak lama lagi

Indonesia mensasarkan penghasilan dua jenis pil antiviral COVID-19 tempatan, Molnupiravir dan Paxlovid pada April atau Mei tahun ini.
Wed Jan 19 2022
COVID-19: AS benarkan penggunaan pil antiviral Merck & Co

COVID-19: AS benarkan penggunaan pil antiviral Merck & Co

Merck merancang untuk menghantar ratusan ribu pek ubat dalam beberapa hari akan datang.
Fri Dec 24 2021
COVID-19: KKM selaras semula pembelian pil antiviral Molnupiravir

COVID-19: KKM selaras semula pembelian pil antiviral Molnupiravir

KKM akan menyelaras semula pembelian ubat antiviral Molnupiravir bagi menyesuaikan keperluan ubat-ubatan bagi rawatan COVID-19.
Mon Dec 06 2021
Thailand beli 2 juta pil Molnupiravir untuk tangani COVID-19

Thailand beli 2 juta pil Molnupiravir untuk tangani COVID-19

Kabinet Thailand meluluskan pelan membeli 50,000 set ubat Molnupiravir atau dua juta pil antivirus COVID-19 itu bagi membendung pandemik di negara berkenaan.
Tue Nov 09 2021
UK becomes first country to approve anti-COVID pill

UK becomes first country to approve anti-COVID pill

The antiviral, called molnupiravir, works by decreasing the ability of a virus to replicate, thereby slowing down the disease.
Fri Nov 05 2021
Gates Foundation allots $120 mln for poor nations to get COVID-19 drug

Gates Foundation allots $120 mln for poor nations to get COVID-19 drug

The commitment will ensure that more people in more countries get access to the promising drug molnupiravir, Melinda said.
Wed Oct 20 2021
Exclusive - WHO-led programme aims to buy antiviral COVID-19 pills for $10 - Document

Exclusive - WHO-led programme aims to buy antiviral COVID-19 pills for $10 - Document

Merck & Co's experimental pill molnupiravir is likely to be one of the drugs, and other drugs to treat mild patients are being developed.
Tue Oct 19 2021
Ubat COVID-19: Penasihat FDA bincang kelulusan Merck bulan depan

Ubat COVID-19: Penasihat FDA bincang kelulusan Merck bulan depan

FDA akan bermesyuarat pada 30 November bagi membincangkan keselamatan dan keberkesanan Molnupiravir.
Fri Oct 15 2021
Merck seeks first US authorization for COVID-19 pill

Merck seeks first US authorization for COVID-19 pill

An authorisation from the FDA could help change clinical management of COVID-19 as the pill can be taken at home.
Tue Oct 12 2021
COVID-19: Merck mohon kelulusan kecemasan pil antiviral Molnupiravir

COVID-19: Merck mohon kelulusan kecemasan pil antiviral Molnupiravir

Ubat keluaran syarikat berkenaan bakal menjadi yang pertama digunakan untuk merawat pesakit COVID-19 jika diluluskan.
Mon Oct 11 2021